microRNA Name:

hsa-miR-26b

Gene Score: 0.0244

Pathway Score: 0.0656

Disease Tissue/ Cell line MicroRNA regulation Targeted Member Pathway More Details References
Gastric cancer Gastric cancer tissue Down KPNA2 JNK signaling pathway MicroRNA-26b suppresses tumor metastasis by inhibiting the JNK signaling pathway in human gastric cancer.
Tsai et al., 2016
Non-small cell lung cancer Lung Down MIEN1 NF-Kappa B signaling pathway MicroRNA-26b inhibits non-small cell lung cancer metastasis by suppressing MIEN1 through NF-Kappa B signaling pathways.
Li et al., 2016
Breast cancer MCF-7 Down REL A NF-Kappa B signaling pathway MicroRNA-26b plays an important role in wound healing and tumor-induced endothelial cell tube formation by down-regulating NF-Kappa B expression.
Anbalagan et al., 2014
Hepatocellular carcinoma Hepatocyte Down MCL1 MCL1 pathway hsa-miR-26b directly targets Mcl-1 mRNA which plays an important role in the sensitization effect of miR-26b on TRAIL-induced apoptosis in HCC. miR-26b/Mcl-1 pathway might act as a sensitizer for chemotherapy.
Jiang et al., 2015
Hepatocellular carcinoma Hepatocyte Down USP9X TGF-beta signaling pathway Overexpression of miR-26b downregulates the expression of USP9X, which in turn affects epithelial-mesenchymal transition of hepatocellular carcinoma cells through TGF-beta signaling pathway.
Shen et al., 2014
Hepatocellular carcinoma Hepatocyte TAK1 NF-Kappa B signaling pathway Overexpression of miR-26b inhibits NF-kappa B signaling pathway and thereby sensitized hepatocellular carcinoma cells to the doxorubicin-induced apoptosis by downregulating the expression of TAK1.
Zhou et al., 2014
Hepatocellular carcinoma Hepatocyte TAB3 NF-Kappa B signaling pathway Overexpression of miR-26b inhibits NF-kappa B signaling pathway and thereby sensitized hepatocellular carcinoma cells to the doxorubicin-induced apoptosis by downregulating the expression of TAB3.
Zhou et al., 2014
Prostate cancer LNCaP, DU145, PC-3 Down ULK2 Autophagy pathway MicroRNA-26b suppresses autophagy in prostate cancer cells by down-regulating ULK2 expression.
Clotaire et al., 2016